TD Cowen Maintains Outperform on Elevance Health, Raises Price Target to $585
Portfolio Pulse from jenniferd'souza@benzinga.com
TD Cowen analyst Gary Taylor maintains an Outperform rating on Elevance Health (NYSE:ELV) and raises the price target from $564 to $585.
July 24, 2023 | 4:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Gary Taylor maintains an Outperform rating on Elevance Health and raises the price target from $564 to $585. This could potentially lead to a positive impact on the stock's price.
The Outperform rating maintained by the TD Cowen analyst indicates a positive outlook for the company. The increase in the price target from $564 to $585 suggests that the analyst expects the stock's price to rise in the short term, which could potentially lead to a positive impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100